Compare UVE & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UVE | SDGR |
|---|---|---|
| Founded | 1990 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 1996 | 2020 |
| Metric | UVE | SDGR |
|---|---|---|
| Price | $43.57 | $15.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $40.00 | $21.00 |
| AVG Volume (30 Days) | 222.8K | ★ 866.1K |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.97% | N/A |
| EPS Growth | ★ 214.43 | 45.14 |
| EPS | ★ 3.93 | N/A |
| Revenue | ★ $1,603,915,000.00 | $255,869,000.00 |
| Revenue This Year | N/A | $0.76 |
| Revenue Next Year | $2.88 | $4.60 |
| P/E Ratio | $23.43 | ★ N/A |
| Revenue Growth | 5.48 | ★ 23.29 |
| 52 Week Low | $22.87 | $10.95 |
| 52 Week High | $45.15 | $23.02 |
| Indicator | UVE | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 59.20 | 45.00 |
| Support Level | $29.85 | $14.61 |
| Resistance Level | $43.68 | $16.47 |
| Average True Range (ATR) | 1.60 | 0.59 |
| MACD | 0.43 | -0.11 |
| Stochastic Oscillator | 79.50 | 21.62 |
Universal Insurance Holdings Inc is an insurance holding company. Through its subsidiaries, the company mainly offers property and casualty insurance and value-added insurance services. It develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners lines of business and performs all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The group offers the following types of personal residential insurance: homeowners, renters/tenants, condo unit owners, and dwelling/fire, through an independent agent network and online distribution channels across multiple states in the United States of America.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.